Ra Medical Systems Inc. (RMED)
AMEX: RMED
· Real-Time Price · USD
0.59
0.05 (9.26%)
At close: Aug 17, 2023, 10:00 PM
Ra Medical Systems Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | 212K | 143K | 5K | 318K | 406K | 484K | 183K | 154K | 586K | 603K | 1.08M | 1.28M | 894K | 1.2M | 1.25M |
| Product Revenue Growth | +48.25% | +2760.00% | -98.43% | -21.67% | -16.12% | +164.48% | +18.83% | -73.72% | -2.82% | -44.06% | -16.04% | +43.62% | -25.56% | -3.77% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Europe Revenue | 39K | 8K | 34K | 33K | 994K | 1.06M | 1.21M | 905K | 881K | 1.19M | 1.35M | 1.62M | 1.95M | 1.65M | 1.94M | 1.99M |
| Europe Revenue Growth | +387.50% | -76.47% | +3.03% | -96.68% | -6.49% | -12.08% | +33.59% | +2.72% | -25.72% | -12.08% | -16.63% | -16.98% | +17.98% | -14.63% | -2.86% | n/a |
| United States Revenue | 173K | 135K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +28.15% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.88M | 3.48M | 3.04M | 2.88M | 2.71M | 2.75M | 1.42M | 10.23M | 7.96M | 3.51M | 2.48M | 2.3M | 4.19M | 4.21M | 3.74M | 4.11M | 6.86M | 4.93M | 7.9M | 6.29M | 8.64M | 15.89M | 13.79M | 13.23M | 14.81M | 5.37M | 7.62M | 2.64M | 3.02M | 1.9M | 8.28M | 1.75M |
| Selling, General, and Administrative Revenue Growth | -17.33% | +14.49% | +5.62% | +6.23% | -1.17% | +93.99% | -86.17% | +28.59% | +126.47% | +41.92% | +7.56% | -45.06% | -0.50% | +12.56% | -9.07% | -40.03% | +39.06% | -37.53% | +25.63% | -27.27% | -45.61% | +15.23% | +4.23% | -10.70% | +176.07% | -29.53% | +188.56% | -12.47% | +58.35% | -77.01% | +374.67% | n/a |
| Research and Development Revenue | 155K | 103K | 214K | 63K | 81K | 112K | 134K | 240K | 154K | 727K | 2.4M | 3.12M | 3.73M | 2.94M | 3.02M | 2.82M | 3.43M | 2.33M | 1.95M | 1.29M | 838K | 1.18M | 979K | 1.53M | 1.24M | 224K | 1.02M | 286K | 359K | 413K | 3.37M | 379K |
| Research and Development Revenue Growth | +50.49% | -51.87% | +239.68% | -22.22% | -27.68% | -16.42% | -44.17% | +55.84% | -78.82% | -69.66% | -23.08% | -16.53% | +26.85% | -2.52% | +7.17% | -17.85% | +47.00% | +19.41% | +50.81% | +54.53% | -29.10% | +20.74% | -36.05% | +23.07% | +455.36% | -78.08% | +257.34% | -20.33% | -13.08% | -87.73% | +788.39% | n/a |